InspireMD, Inc. (NSPR)
Oxford Ledge is still expanding full research coverage of NSPR. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company is conducting two clinical trials to expand regulatory approvals for carotid intervention devices, facing risks that trials may be delayed or fail to demonstrate safety and effectiveness.
SEC filings
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-07-02
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-11
- 8-K Amendments to articles or bylaws; Shareholder vote results; Financial statements and exhibits 2026-06-03
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-05-22
- 10-Q Quarterly financial report (unaudited) 2026-05-07
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for NSPR. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open NSPR in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.